en
Scientific article
English

β-Lactam Monotherapy vs β-Lactam-Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia: A Randomized Noninferiority Trial

Published inJAMA internal medicine, vol. 174, no. 12, p. 1894-1901
Publication date2014
Abstract

The clinical benefit of adding a macrolide to a β-lactam for empirical treatment of moderately severe community-acquired pneumonia remains controversial.

Citation (ISO format)
GARIN, Nicolas et al. β-Lactam Monotherapy vs β-Lactam-Macrolide Combination Treatment in Moderately Severe Community-Acquired Pneumonia: A Randomized Noninferiority Trial. In: JAMA internal medicine, 2014, vol. 174, n° 12, p. 1894–1901. doi: 10.1001/jamainternmed.2014.4887
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal2168-6106
652views
0downloads

Technical informations

Creation11/15/2014 1:54:00 PM
First validation11/15/2014 1:54:00 PM
Update time03/14/2023 10:29:22 PM
Status update03/14/2023 10:29:21 PM
Last indexation01/16/2024 3:17:32 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack